Related Experiment Video

Updated: Jun 5, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency

A A Yassin1, F Akhras, A I El-Sakka

  • 1Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt-Hamburg, Germany. yassin@t-online.de

Andrologia
|January 12, 2011
PubMed

Insights

Low testosterone in aging men is linked to cardiovascular disease, type 2 diabetes, and erectile dysfunction. Addressing testosterone deficiency is crucial for managing these common age-related conditions.

Area of Science:

  • Endocrinology
  • Geriatrics
  • Cardiology
  • Metabolic Health

Background:

  • Cardiovascular disease (CVD), type 2 diabetes mellitus (DM), and sexual dysfunction were traditionally viewed as independent conditions in aging men.
  • Recent research highlights the interconnectedness of these clinical conditions.
  • Declining testosterone levels in elderly men are increasingly recognized as a central factor in these pathologies.

Purpose of the Study:

  • To investigate the central role of declining testosterone levels in aging men.
  • To explore the relationship between testosterone deficiency and conditions such as CVD, DM, and erectile dysfunction.
  • To emphasize the importance of testosterone measurement in the management of these age-related diseases.

Main Methods:

  • Review of current literature on testosterone levels and age-related diseases.
  • Analysis of the physiological links between testosterone, endothelial function, and metabolic syndrome.
  • Correlation of clinical observations with hormonal status.

Main Results:

  • Erectile dysfunction is now understood as a manifestation of endothelial dysfunction.
  • Testosterone deficiency is associated with a higher incidence of CVD and DM.
  • Visceral obesity, a key feature of metabolic syndrome, impairs testosterone production by suppressing the hypothalamic-pituitary-testicular axis.

Conclusions:

  • Testosterone deficiency is significantly correlated with CVD, DM, and erectile dysfunction.
  • Androgen deficiency can lead to symptoms of metabolic syndrome.
  • Routine testosterone level measurement is recommended for patients with CVD, DM, and erectile dysfunction.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...